Skip to main content
Clinical Trials/NCT05791084
NCT05791084Not yet recruitingNot Applicable

Supporting Women With Left Sided Breast Cancer to Practice Deep Inspiration Breath Hold (DIBH) at Home Before Radiation Therapy Treatment

Jonkoping University0 sites160 target enrollmentStarted: September 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
160
Primary Endpoint
Distress (DIS-A)

Study Overview

Brief Summary

To examine the effect of a preparatory digital tool including a new instruction for deep inspiration breath hold (DIBH), before start of radiation therapy in women diagnosed with left sided breast cancer, compared with usual care.

Detailed Description

The following questions will be posted:

  • Are there any differences in levels of distress (primary outcome) between the control and intervention group at baseline and over time?
  • Are there any differences in preparedness for RT (secondary outcomes) between the control and intervention group at baseline and over time?
  • Are there any correlations between Health Literacy (HL) levels (secondary outcome) and levels of distress (primary outcome) in the control and intervention group?
  • Are there any differences in objective clinical variables (chest mobility and respiratory movements and planned absorbed dose to the heart) between the control and intervention group before and after the intervention (baseline and at planning CT)?
  • Which patterns of practice and use of the application (when, how, how often and for how long) can be discerned from the intervention group?
  • Are there any correlations between different levels of practice and use of the digital tool and primary and secondary outcomes?
  • How do patients in the different groups (control and intervention group) describe their experience of care and information process during RT with DIBH?
  • Are there differences regarding health economic variables in terms of costs and health care usage (e.g., estimated time for planning and conducting computed tomography (CT), number of scheduled CT examinations) and patient effects (e.g. co-morbidities (heart related), sick leave, and quality-adjusted life year (QALYs) between patients in control- or interventions group?
  • Are there any differences regarding effects on environmental aspects and costs in the different groups (control and intervention)?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Inclusion criteria for the study:
  • •patients > 18 years of age
  • •with a left-sided breast cancer diagnosis or DCIS
  • •who are to receive RT with DIBH technology
  • •with curative intention
  • •preparatory CT visit minimum 7 days to a maximum of 4 weeks
  • •able to speak and understand good enough Swedish to be able to assimilate content in the mobile app and answer surveys and interview questions
  • •have access to a smart mobile phone.

Exclusion Criteria

  • •patients receiving palliative RT or neoadjuvant chemotherap
  • •Planning CT starting < 7 days
  • •people with some form of orthopedic, rheumatological or neurological injury or disease that limits the possibility of carrying out the intervention.

Arms & Interventions

A=Control group who receives customary information prior to RT with DIBH.

No Intervention

Usual care and information before start of radiotherapy with DIBH.

B=Intervention group usual care and the DIBH-App to practice at-home before RT with DIBH.

Experimental

Usual care and information and a mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts.

Intervention: mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts. (Other)

Outcomes

Primary Outcomes

Distress (DIS-A)

Time Frame: time 5, 5 years after RT

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Distress (DIS-A)

Time Frame: Time 1, baseline at randomisation/inclusion

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Distress (DIS-A)

Time Frame: time 2, at CT-planning visit one week

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Distress (DIS-A)

Time Frame: time 3, 3 weeks post RT

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Distress (DIS-A)

Time Frame: time 4, 6 month post RT

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Secondary Outcomes

  • HRQoL and Health economic (EQ-5D-5L)(5 years post RT)
  • e-HL (eHLQ)(at baseline when inclusion/randomisation)
  • Communicative, critical and functional HL(at baseline when inclusion/randomisation)
  • Preparedness(PCSQ-24)(at CT planning visit, one week)
  • The Radiotherapy Experience Questionnaire, Swedish modified version(3 weeks post RT)
  • HRQoL and Health economic (EQ-5D-5L)(at baseline when inclusion/randomisation)

Investigators

Sponsor
Jonkoping University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Maria Brovall

associated professor

Jonkoping University

Similar Trials